Branch Therapeutics is developing first-in-class oral dual-pathway inhibitors that prevent cancer recurrence and block tumor proliferation. With lead programs in colorectal cancer and glioblastoma, our therapies target both cancer stem cell survival and proliferative signaling, transforming breakthr... Read more
Org chart
This company has no org chart yet
Teams
This company has no teams yet
Offices
This company has no offices yet
